Consumer Discretionary
Highlights Portfolio Strategy Firming relative demand and input cost dynamics, the Medicare For All (MFA)-induced panic selling in HMOs coupled with 5G euphoria buying in semis have set the stage for an exploitable pair trade opportunity: long S&P managed health care/short S&P semiconductors. Relative supply/demand dynamics, crumbling lumber prices, lower interest rates and compelling valuations and technicals all suggest that the long homebuilding/short home improvement retail pair trade is in the early innings. Recent Changes Initiate a long S&P managed health care/short S&P semiconductors trade today, with a tight stop loss at -7%. Table 1 Feature Equities hit a speed bump last week, as President Trump’s trade related tweets instilled some fear back into the markets. Investor complacency reigned supreme and, given the liquidity crunch, risk premia exploded higher with the VIX more than doubling from the recent lows. Historically, a parabolic rise in policy uncertainty is synonymous with an equity market selloff and a widening in risk premia; last week was no different (economic policy uncertainty shown inverted, second panel, Chart 1). Adding insult to injury, given that the forward P/E multiple expansion explained all of the equity market’s advance year-to-date as we highlighted three weeks ago, the trade-related melt up in policy uncertainty caused a mini meltdown in the forward multiple as financial conditions tightened (financial conditions shown inverted, third panel, Chart 1). The implication is that short-term equity market caution is still warranted as we have been writing over the past few weeks, at least until the U.S./China trade dispute dust settles. Chart 1Caution Still Warranted Chart 2Tenuous Trio The recent simultaneous rise of three asset classes, that we call “the tenuous trio”, warned that something had to give: stocks, bond prices and the trade-weighted U.S. dollar cannot all go up in tandem for an extended period of time. When this happens it is typically a forewarning of an equity market snap (Chart 2). One simple explanation is that a rising greenback comes back and haunts equities via a negative P&L hit, albeit with a lagged effect. Irrespective of where the U.S. dollar will move in the coming months, it will continue to weigh on EPS as the surge in the greenback took root from April to November last year. Thus, with a six-to-nine month lag it will continue to infiltrate EPS and Q2 – which the sell-side already expects to barely breach year ago levels – will also feel the U.S. dollar’s wrath. Were the dollar to continue its ascent from current levels, it would put in jeopardy the back half of this year’s EPS growth numbers, especially Q4/2019 that sell-side analysts forecast to jump to 8%, according to I/B/E/S data. This week we recommend putting on a new pair trade involving an unloved health care subgroup and a mighty tech sector subindex but with a tight stop, and also update an intra-consumer discretionary market-neutral housing-levered pair trade. Importantly, the 12-month forward EPS number is artificially rising. Chart 3 shows that calendar 2019 and 2020 EPS estimates continue to build a base, but the 12-month forward number has been rising since early-February. What explains the increase in the 12-month forward estimate is arithmetic. In other words, despite a multi-month downgrading of calendar 2019 and 2020 EPS, the first two quarters of next year are forecast to come in significantly higher than 2019’s first six months. As the latter roll off and the former get added to the 12-month forward EPS number, a deceiving jump occurs. For next year, we continue to expect $181 EPS, and we would lean against the double-digit EPS growth in 2020 that the sell-side currently forecasts. Our top down macro S&P 500 EPS model softened anew recently, warning that mid-single digit growth, at best, is more likely than low double-digit growth (Chart 4). Chart 3Artificial EPS Rise Chart 4SPX Macro EPS Model Forecasts Softness Finally, one of the tech sector’s invincible subgroups is cracking with the S&P semis relative performance hitting a wall both versus the broad market ex-TMT and versus the NASDAQ 100. This is significant not only from a sentiment perspective, but also because semis have high international sales exposure in general and China in particular (Chart 5). Chart 5Vertigo Warning This week we recommend putting on a new pair trade involving an unloved health care subgroup and a mighty tech sector subindex but with a tight stop, and also update an intra-consumer discretionary market-neutral housing-levered pair trade. New High-Octane Pair Trade Idea While health care and tech stocks started the year on a similar footing, a wide gulf has opened that is likely to, at least partially, reverse in the back half of the year. This dichotomy is most evident at the subsector level where managed health care stocks are still down in absolute terms for the year, whereas chip stocks are up roughly 20% year-to-date (Chart 6). This is an exploitable gap and today we suggest a new pair trade: long S&P managed health care/short S&P semiconductors. Chart 6Exploitable Reversal Looms Bernie Sanders’ revamped MFA bill sent the managed health care group to the ER. While there is heightened uncertainty surrounding MFA and we are working on a joint Special Report with our sister Geopolitical Strategy service due on June 3rd, this is likely a 2022 story. Not only will Sanders have to win the Democratic candidacy and subsequently the Presidential election, but also the GOP would have to lose the Senate. This is an extremely low probability event that has dealt a massive blow to HMO stocks. On the flip side, semis are priced for perfection. The recent catalyst for this group’s stratospheric rise was Apple’s patent settlement with Qualcomm that set in motion a 5G-related euphoria. Again 5G is a late-2021 story and a lot of good news is already priced in to semis stocks. Moreover, historically, semi cycles last four-to-five quarters and investors’ neglect of the semi downcycle is puzzling as we have recently concluded just two down quarters. Explicitly, what is truly baffling is that 12-month forward EPS are slated to contract in absolute terms and forward sales are hovering near the zero line, yet the Philly SOX index recently vaulted to all-time highs. Taken together, we would lean toward health care insurers at the expense of semiconductor stocks. Netting it all out, relative demand and input cost dynamics, the MFA-induced panic selling in HMOs coupled with 5G euphoria buying in semis have set the stage for an exploitable pair trade opportunity: long S&P managed health care/short S&P semiconductors. With regard to relative macro drivers, managed health care has the upper hand. Chart 7 shows that relative demand dynamics clearly favor HMOs and are working against chip stocks. Non-farm payroll growth is trouncing global semi billings. The message from the small business sector is similar with the labor market upbeat compared with declining global semi revenues. Finally, on the relative pricing power gauge front, overall wage inflation is outpacing DRAM prices. On all three fronts, the message is to expect a mean reversion higher in the relative share price ratio. Chart 7Buy Managed Health Care… Chart 8…At The Expense… Input cost/inventory dynamics suggest that HMOs also have the advantage. The health care insurance employment cost index is growing on a par with inflation, but semi industry employment is climbing at a rate over 5%/annum (bottom panel, Chart 8). Taking stock of medical cost inflation, costs are still melting, however global semi inventories are expanding. The upshot is that relative share prices have ample upside (middle panel, Chart 8). Finally, the previous relative valuation overshoot has returned to the neutral zone and, encouragingly, relative technicals are probing multi-year lows near one standard deviation below the historical mean. Importantly, over the past two decades every time our Technical Indicator has hit such a depressed level, a playable rebound in relative share prices has ensued (bottom panel, Chart 9). Chart 9…Of… Chart 10…Semis Nevertheless, this highly volatile market-neutral trade faces one big risk we previously alluded to: relative profit expectations are extended. In other words, the bombed out S&P semiconductor forward EPS and revenue projections are masking the relative profit and revenue backdrop (Chart 10). Netting it all out, relative demand and input cost dynamics, the MFA-induced panic selling in HMOs coupled with 5G euphoria buying in semis have set the stage for an exploitable pair trade opportunity: long S&P managed health care/short S&P semiconductors. Bottom Line: Initiate a long S&P managed health care/short S&P semis pair trade today with a stop loss at the -7% mark. The ticker symbols for the stocks in the S&P managed health care and S&P semi indexes are: BLBG: S5MANH – UNH, ANTM, HUM, CNC, WCG and BLBG: S5SECO – INTC, AVGO, TXN, NVDA, QCOM, MU, ADI, XLNX, AMD, MCHP, MXIM, SWKS, QRVO, respectively. Homebuilding/Home Improvement Retail Pair Trade Update In late-January we put on a market, sector and subindustry neutral trade preferring homebuilders to home improvement retailers (HIR) as a way to benefit from the increase in residential construction at the expense of residential investment. This trade moved in the black from the get-go and is now generating alpha to the tune of 7% since inception, but more gains are in store in the coming months. President Trump’s hawkish tariff rhetoric should keep interest rates at bay, at least for a short while, and bond market nervousness is more of a boon to homebuilders than to HIR (top panel, Chart 11). The drop in the price of mortgage credit along with minor price concessions from homebuilders are causing sales of new homes to take off versus existing home sales (middle panel, Chart 11). Granted, bankers remain willing extenders of residential loans and the latest Fed Senior Loan Officer Opinion Survey revealed that demand for residential credit is making a comeback following a near yearlong decline (not shown). As a result, relative loan growth metrics also underpin the relative share price ratio (bottom panel, Chart 11). Chart 11Still In Early Innings In sum, relative supply/demand dynamics, crumbling lumber prices, lower interest rates and compelling valuations and technicals all suggest that the long homebuilding/short HIR pair trade is in its early innings. Importantly, the new/existing home sales–to-inventory ratio is an excellent leading indicator of relative share prices and is currently emitting an unambiguously bullish signal for homebuilders at the expense of HIR (Chart 12). Chart 12Supply/Demand Backdrop Says Stick With This Pair Trade Chart 13Relative Sales ##br##Expectations… Examining the relative demand backdrop reveals that homebuilders will continue to outshine HIR. Current readings in the NAHB home sales survey versus the remodeling survey and future expectations both point to more gains in the relative share price ratio (Chart 13). The felling in lumber prices also represents a benefit to homebuilders to the detriment of HIR. Lumber is a key building input cost in new home construction so any price liquidation is a boon for homebuilding margins. In contrast, HIR makes a set margin on lumber sales, therefore deflating lumber prices cut HIR profits (Chart 14). Chart 14…Felling Lumber Prices And … Chart 15…Bombed Out Valuations Signal More Relative Share Price Gains Finally, on the relative valuation and technical fronts, there is anything but froth. In fact, the relative price to book ratio is perched near an all-time low and relative momentum has only recently troughed and has yet to reach the neutral zone (Chart 15). In sum, relative supply/demand dynamics, crumbling lumber prices, lower interest rates and compelling valuations and technicals all suggest that the long homebuilding/short HIR pair trade is in its early innings. Bottom Line: Stick with a long S&P homebuilders/short S&P HIR pair trade. The ticker symbols for the stocks in the S&P homebuilding and S&P HIR indexes are: BLBG: S5HOME – PHM, DHI, LEN and BLBG: S5HOMI – HD, LOW, respectively. Anastasios Avgeriou, U.S. Equity Strategist anastasios@bcaresearch.com Current Recommendations Current Trades Size And Style Views Favor value over growth Favor large over small caps
Highlights Portfolio Strategy China’s ongoing reflation trifecta, rising commodity prices, a back-half of the year global growth recovery, favorable balance sheet metrics and neutral valuations and technicals all signal that the cyclical vs. defensive outperformance phase has more running room. New home-related data releases have been a mixed bag lately and there are high odds that homebuilders have discounted all the good housing market news. Be prepared to book profits. Recent Changes There are no changes in our portfolio this week. Table 1 Feature The SPX hit fresh all-time closing highs last week, as declining profits were not as bad as previously feared. While economic and profit fundamentals remain soft at best, fear of missing out (FOMO) on the rally and proliferating talk of a melt up in stocks have provided the needed spark to fuel the recent equity breakout (Chart 1). Historically, both of these sentiment/anecdotal-type time series have led or coincided with temporary broad equity market peaks and we continue to believe that some short-term caution is still warranted. In other words, we would not chase this multiple expansion-driven market advance and specifically refrain from putting fresh capital to work (please refer to Charts 1 & 2 from last Monday’s Weekly Report)1. Moreover, the easy money on the “reflation trade” has already been made and now the risk/reward tradeoff is to the downside. Our Reflation Gauge (RG), comprising oil prices, the trade-weighted U.S. dollar and interest rates, is quickly losing steam and warns against extrapolating equity market euphoria far into the future (Chart 2). Chart 1Beware Melt Up And FOMO Narrative Chart 2Reflation Stalling As a reminder, crude oil prices are up over 50% from the nadir, the 10-year Treasury yield is up 25bps from the recent lows, and the greenback is on the cusp of a breakout in level terms. The implication from our decelerating RG is also consistent with a cautious equity market stance from a tactical perspective. But, on a cyclical 9-12 month time horizon we continue to have a sanguine equity market view as the U.S. will avoid recession and the Fed will likely stay on the sidelines. We recently updated the S&P 500 dividend payout for calendar 2018 and this week we are introducing our 3,150 SPX target for end-year 2020 derived via three methodologies: SPX dividend discount model (DDM), forward multiple/EPS sensitivity and forward equity risk premium (ERP) analysis. Table 2 summarizes our results. On a side note our end-year 2019 target remains unchanged since our mid-January update at 3,000.2 Table 2SPX Target Using Three Different Methods In all three ways we get a value of roughly 3,150 on the SPX, which serves as our end-year 2020 SPX target. In our DDM, we moved the recession to 2021 from 2020 previously, added a year to our 5-year rolling estimates and continue to conservatively assume no buybacks. With regard to the sensitivity analysis, our 2021 EPS estimate is $191, a discount to the $205 currently penciled in by the sell-side, and our base case calls for a 16.5x forward multiple. Finally, the bottom part of Table 2 shows our forward ERP assumptions. We lifted the equilibrium ERP from 200bps to 250bps given the recent setback it suffered and our 10-year Treasury yield also moved down 50bps to 3.5%. Consistent with our sensitivity analysis base case, the starting point is $191 2021 EPS. In all three ways we get a value of roughly 3,150 on the SPX, which serves as our end-year 2020 SPX target. (If you would like to receive our excel spreadsheet in order to adjust our assumptions please email our client requests department here). This week we update our cyclicals/defensives portfolio bent view and a set a stop sell order to an overweight early-cyclical niche subsector. Stick With Cyclicals Over Defensives, For Now Chart 3China… We were early and right in January when we posited that China’s slowdown was yesteryear’s story and more than discounted in the collapse of the U.S. cyclicals vs. defensives ratio (please refer to Chart 5 from the January 28 Weekly Report). Similarly, in early February when everyone was laser focused on the Fed’s January meeting, our report titled “Don’t Fight The PBoC” highlighted that the Chinese were serious about reflating their economy. The PBoC’s quasi-QE not only recapitalized the banks, but it also injected enormous liquidity into their financial system. The upshot was that U.S. cyclicals would reclaim the upper hand vs. defensives. Now as the story count for “China Slowdown” is coming down fast (story count shown inverted, bottom panel, Chart 3) the question is how much of the looming Chinese recovery is currently priced in the V-shaped cyclical/defensives rebound? Our sense is that while most of the good news is largely reflected in the slingshot recovery in the relative share price ratio, there is some room left for additional gains. Financial variables are upbeat and signal that more gains are in store for the cyclicals/defensives ratio. China’s A-shares year-to-date have trounced the S&P already by a factor greater than 2:1 (in local currency terms, not shown). The MSCI China index is also outperforming the MSCI All-Country World Index (top panel, Chart 4). Sell-side analysts are in synchrony with the markets and they have been upgrading EPS estimates for the MSCI China index (top panel, Chart 5). Chart 4…Signals… Beyond the stock market, the FX market along with commodities are also underpinning relative share prices. The ADXY index (bottom panel, Chart 4) and the CRB metals index (bottom panel, Chart 5) are both moving in lockstep and suggest that commodity related profits will boost cyclicals at the expense of defensives. Chart 5…More Gains… Similarly, the broad trade-weighted U.S. dollar is no longer appreciating at the late-2018 breakneck pace and, at the margin, suggests that cyclicals profits will get an added boost from positive FX translation gains as they garner a larger slice of their revenue from international markets compared with mostly domestically-exposed defensives (U.S. dollar shown inverted, bottom panel, Chart 6). Soft economic data have taken their cue from higher frequency financial market data and have also turned. China’s CAIXIN manufacturing PMI is above the 50 boom/bust line. The implication is that U.S. cyclicals’ profits will outshine U.S. defensives’ EPS (middle panel, Chart 6). Finally, monetary easing is ongoing on the Chinese front. The banks’ reserve-requirement-ratio is falling and so is the interbank lending rate as per SHIBOR (both shown inverted & advanced, top & middle panel, Chart 7). Given the trifecta of Chinese easing on the monetary, fiscal and credit front, it is inevitable that hard data will also soon turn. Chart 6…Are In Store For Cyclicals… Chart 7…At The Expense Of Defensives Chart 8Global LEI Diffusion Concurs Nevertheless, it is not only China that is emitting an unambiguously positive signal for the U.S. cyclicals/defensive ratio. BCA’s global leading economic indicator diffusion index is pushing 65%, underscoring that the majority of the countries we track showcase an improving economic outlook. As a reminder, BCA’s view remains that in the back half of the year global growth will pick up steam. Thus, under such a backdrop, cyclicals will continue to outperform defensives (Chart 8). Stick with a cyclical over defensive portfolio bent, but stay tuned. On the relative operating front, cyclicals are also flexing their muscles and crushing defensives. Since 1980 (the beginning of our dataset), the cyclical/defensive portfolio bent has followed relative return-on-assets (ROA). While over the decades there have been some divergences, this correlation has become extremely tight since early-2000. Currently, following the late-2015/early 2016 manufacturing recession, the relative ROA has jumped 400bps and is signaling that relative share prices are on a solid footing (Chart 9). Chart 9Relative ROA And… With regard to relative debt dynamics, cyclicals also have the upper hand. Net debt/EBITDA and EBIT/interest expense both show that the relative indebtedness favors cyclicals over defensives. While defensives are degrading their balance sheet, cyclicals are still repairing theirs in the aftermath of the recent manufacturing recession (Chart 10). Despite the year-to-date spike in relative share prices, relative valuations and technicals remain tame. Both our relative Valuation and Technical Indicators are timid, and remain below the respective historical averages (Chart 11). Chart 10…Indebtedness Suggests That Cyclicals Have the Upper Hand In sum, China’s ongoing reflation, rising commodity prices, a back-half of the year global growth recovery, favorable balance sheet metrics and neutral valuations and technicals all signal that the cyclical vs. defensive outperformance phase has more running room. Chart 11No Red Flags Bottom Line: Stick with a cyclical over defensive portfolio bent, but stay tuned. Is The Homebuilding Rally Sustainable? While we were slightly early in our upgrade of homebuilding stocks to overweight in late-September, this recommendation has generated alpha close to 10% for our portfolio. Nevertheless, some soft housing related data compel us to put this index on downgrade alert and, from a risk management perspective in order to protect gains, set a stop sell order near the 10% relative return mark. Just to be clear, this is not a negative call on residential real estate. Quite the opposite, housing market long-term drivers remain upbeat in the U.S. Chart 12 shows that household formation is still running higher than housing starts and building permits. This is a bullish industry supply/demand backdrop. Housing affordability, while not as sky-high as when house prices troughed in 2011/2012, remains above the historical mean and above previous peaks (second panel, Chart 12). Tack on still generationally low interest rates and there good odds that first-time home buyers will return to the residential real estate market. Finally, the labor market is as good as it gets with the unemployment rate plumbing multi-decade lows (unemployment rate shown inverted, bottom panel, Chart 12). Job certainty and rising salaries are a healthy combination for housing market prospects. Beyond the positive structural housing market forces, some recent homebuilder specific data have also been positive. New home sales have surged and are now in expansionary territory (top panel, Chart 13). Similarly, the latest inventory data on new homes showed that newly built house inventories are whittled down, with the months’ supply metric falling by over one month (new house supply shown inverted, second panel, Chart 13). Chart 12Bullish Structural Housing Fundamentals Chart 13Select Positive… The 70bps drop in the 30-year fixed mortgage rate since November has shown up in rising mortgage purchase applications that have vaulted to multi-year highs (middle panel, Chart 13). Lumber, a key input cost for new home construction has melted of late and this building material cost relief is a boon for homebuilding margins. True, new home prices are deflating and are an offset, but from an all-time high level and at a slower pace than lumber prices (fourth & bottom panels, Chart 13). One reason median new single family home prices are falling is that homebuilders are competing aggressively for market share with the existing stock of homes available for sale. Price concessions are paying dividends as relative volumes have spiked i.e. homebuilders are successfully grabbing market share (second & third panels, Chart 14). In absolute terms, S&P homebuilding sales are expanding at a healthy pace and the NAHB’s survey of future sales expectations point to a firming new home demand outlook (bottom panel, Chart 14). However, there are some macro headwinds that homebuilders will have to contend with in the back half of the year. While interest rates have fallen during the past six months, our fixed income strategists expect a selloff in the bond market, which, at the margin, will weigh on housing affordability (mortgage rate shown inverted, top panel,Chart 15). Chart 14…Homebuilding Data… Chart 15…But Two Key Risks Remain Netting it all out, housing related data have been a mixed bag of late and homebuilders have likely discounted most of the good housing market news. Thus, in order to protect profits we are setting a stop sell order near the 10% relative return mark. Already, bankers are making it slightly, but steadily, more difficult to get a mortgage loan (third panel, Chart 15). But, what worries us most is that according to the Fed Senior Loan Officer survey, demand for residential real estate loans has collapsed to a level last hit at the depths of the Great Recession. Historically, this bombed out demand indicator has been a precursor of a fall in relative share prices (second panel, Chart 15). Finally, actual mortgage loan origination is quickly decelerating (bottom panel, Chart 15) and short-term momentum is already contracting. Netting it all out, housing related data have been a mixed bag of late and homebuilders have likely discounted most of the good housing market news. Thus, in order to protect profits we are setting a stop sell order near the 10% relative return mark. Bottom Line: Stay overweight the S&P homebuilding index, but we are putting it on our downgrade watch list. Be prepared to monetize gains on a pullback in relative share prices near the 10% return mark since inception. The ticker symbols for the stocks in this index are: BLBG: S5HOME – PHM, DHI, LEN. Anastasios Avgeriou, U.S. Equity Strategist anastasios@bcaresearch.com Footnotes 1 Please see BCA U.S. Equity Strategy Weekly Report, “Mixed Signals” dated April 22, 2019, available at uses.bcaresearch.com. 2 Please see BCA U.S. Equity Strategy Weekly Report, “Catharsis” dated January 14, 2019, available at uses.bcaresearch.com. Current Recommendations Current Trades Size And Style Views Favor value over growth Favor large over small caps
The relative resilience of consumer discretionary stocks has been puzzling over the past two years. Typically, rising interest rates prelude a period of underperformance in these highly rate sensitive stocks (fed funds rate shown inverted, bottom panel) but…
Underweight The relative resilience of consumer discretionary stocks has been puzzling over the past two years. Typically, rising interest rates prelude a period of underperformance in these highly rate sensitive stocks (fed funds rate shown inverted, bottom panel) but the divergence has grown exceptionally wide. Regardless, we believe our negative thesis is sound. Consumer confidence is near record highs (though it has started to decline), which appears to be driving the relative share price gains but consumer credit has not followed suit (second panel), implying consumers are not backing up their positivity with their wallets. The sell-side too appears to discount soaring consumer confidence as earnings estimates have not kept pace with share prices, driving sector valuations to a 25% premium to the broad market and well above sustainable average levels (third panel). However, this is partially explained by Amazon, which carries roughly 30% weight in the S&P consumer discretionary index but only 12.5% of operating profit, and its exceptional outperformance since the beginning of 2018. Nonetheless, we expect retail sales to follow the opposite path of interest rates, as it always has in past cycles, and a derating to occur. Bottom Line: We reiterate our below-benchmark allocation rating on the S&P consumer discretionary index as valuations have grown excessive and BCA’s view remains that interest rates are near their trough.
Overweight The S&P homebuilders index has been outperforming nicely so far this year on the back of renewed optimism in the domestic housing market. This is reflected in the V-shaped recovery from the end-of-year homebuilder blues in 2018 (second panel). Further, Lennar, the largest constituent firm of the S&P homebuilders index reported Q1 results this week that noted record orders through the first two months of the year. In their earnings release, Lennar highlighted a pullback in mortgage rates as the largest rationale behind resurgent demand; as the principal driver of house affordability (mortgage rates shown inverted, third panel), this is unsurprising. Still, housing starts data, also released this week, was tepid in the context of generationally low unemployment and firm household formation (bottom panel). We believe it is only a matter of time before housing starts catch up with increasing affordability-fueled demand and reiterate our overweight recommendation. We further express this view through a long S&P homebuilding/short S&P home improvement retail pair trade that we also reiterate.1 The ticker symbols for the stocks in this index are: BLBG: S5HOME - DHI, LEN, PHM. 1 Please see BCA U.S. Equity Strategy Report, “ Dissecting 2019 Earnings”, dated January 22, 2019, available at uses.bcaresearch.com
The share of residential investment as a percentage of GDP has been steadily decreasing over the past 70 years, and is down to just 3% today. Although housing remains an important component of the U.S. economy and large fluctuations in the space will surely…
Underweight The S&P hotels, resorts and cruise lines index has been trading sideways for the last several months. Weakness in the cruise lines half of the index has been offset by relative outperformance by hotels, specifically Hilton, who released better than expected Q4 results last month. The market cheered the results, despite the company trimming this year’s revenue per available room guidance. We think the lowered guidance bears scrutiny. Domestic capacity has been rapidly expanding for the past seven years and while pricing has been resilient for much of that time, it is likely only a matter of time before the pricing reacts to the dramatic supply increase, let alone the ongoing Airbnb threat (construction spending shown inverted and advanced, second panel); Hilton’s guidance appears to confirm this. Meanwhile, a tight labor market is driving a recovery in sector wages which will provide added pressure to margins if prices falter (third panel). All of this is captured by our earnings model which indicates earnings underperformance should persist (bottom panel). Bottom Line: Headwinds to hotel earnings should remove the remaining support for the S&P hotels, resorts and cruise lines index; stay underweight. The ticker symbols for the stocks in this index are: BLBG: S5HOTL - MAR, CCL, RCL, HLT, NCLH.
Dear Client, I am travelling this week so this report is a joint effort juxtaposing two contrasting observations about France. The ‘opulence’ part highlights France as the world’s dominant producer of luxury goods, and makes the case that some of the French luxury goods companies should form a core part of a long-term investment portfolio. The ‘rebellion’ part borrows from a recent Special Report on French politics penned by my colleague Jeremie Peloso. It analyses the recent yellow vest protests in France, and assesses whether they are a cause for concern. Best regards, Dhaval Joshi, Chief European Investment Strategist Feature Opulence Made In France Global luxury goods sales amount to a quarter of a trillion dollars, and Europe dominates in the production of these luxury goods. Measured by the number of companies, the leading luxury goods country is Italy. But on the more important metric of share of total global sales, the undisputed world leader is France. In fact, just four French companies produce a quarter of the world’s luxury goods sales. The four are: LVMH, Kering, L’Oreal, and Hermes1 (Chart of the Week, Chart I-2, and Table I-1). France’s luxury goods sector is an excellent diversifier for investors. This is because, compared to other goods and services, luxuries follow very different laws of economics: The demand for luxuries has a positive elasticity to price. Put more simply, the desirability of a luxury increases as its price goes up. This is opposite to the demand for non-luxuries which has a negative elasticity to price: for non-luxury items, the demand declines as the price goes up. By definition, you cannot compete with a luxury item by undercutting its price. Given that a luxury implies fine-craftsmanship rather than mass production, the sector is highly resilient to the existential threats confronting other European industries that emanate from out-sourcing to lower cost economies and from automation. Luxury demand is also relatively insensitive to exchange rate movements. The barrier to entry into the luxuries sector is extremely high. It takes years, or even decades, for a luxury item to acquire its premium status based on consistent high quality in materials and craftsmanship. This high barrier to entry makes it much harder for other economies to challenge the European and French dominance in providing these luxury products. Despite these attractive characteristics the sector does still require a source of structural demand. Our premise, expounded in our Special Report “Buying European Clothes: An Investment Megatrend”, is that the feminisation of consumer spending, particularly in Europe, is providing a strong structural tailwind to the demand for ‘soft’ luxury goods. A recent industry study by Deloitte corroborates this thesis, pointing out that the strongest growth in the luxury sector is to be found in cosmetics, fragrances, bags and accessories. On this premise, the four leading French companies are big beneficiaries.2,3 Are market valuations already aware of, and fully discounting, the thesis of feminisation of consumer spending? We think not, as most investors are surprised by the thesis and unaware of the on-going dynamics behind it. On this basis, three of the four French luxury companies, trading on forward PE multiples in the 20s or below, still appear reasonably valued for their growth prospects (Table I-2). The exception is Hermes which, on a multiple of 40, does seem richly priced. The bottom line is that the three other leading French luxury goods companies – LVMH, Kering, and L’Oreal – do deserve to be a core part of a long-term investment portfolio. Rebellion Made In France The yellow vest protest movement is not a coherent force led by a clear leadership. What started on the social media as a protest against the fuel tax in rural areas has evolved into a movement against President Macron. This transition occurred in part because a large segment of the population believes that Macron’s reforms have mainly benefited the wealthy. 77 percent of respondents in a recent poll view him as the “president of the rich.” The modification of the ‘wealth tax’ – which mostly shifts the focus toward real estate assets instead of financial assets – was highly criticized for favouring the wealthiest households. It resonated strongly with the perception that past governments helped the wealthiest households to accumulate more wealth on the back of the middle class. But it is not clear how intense or durable this popular sentiment will be, given that this type of inequality is not extreme in France and has not been rising (Chart I-3). Chart I-3What Income Inequality? Public support for the protests has hovered consistently around 70 percent since they started in November 2018 (Chart I-4). However, there are now more respondents who think that the protests should stop as that they should continue (Chart I-5). As a sign of things to come, a demonstration against the yellow vests and in support of Macron and his government – held by the “red scarves” – managed to gather more people on the streets of Paris than the regionally based yellow vests have done in the capital city.4 Who are the yellow vests? They are mostly rural, mostly hold a high school degree (or less), and overwhelmingly support anti-establishment political leaders Marine Le Pen (right-wing leader of the National Rally) or Jean-Luc Mélenchon (left-wing leader of La France Insoumise). This suggests that the movement has failed to cross the ideological aisle and win converts from the centre (Diagram I-1). How many French people are actually protesting? Although there was a slight pickup in protests at the beginning of January, the numbers countrywide are not high. In fact, they are far from what they were back in November and therefore would have to get much larger for markets to become concerned anew (Chart I-6). If we are to compare these protests to those in 1995 or 2010, the numbers pale in comparison (Table I-3). For instance, the protest of December 1995 brought a million people onto the streets while the demonstrations against the Woerth pension reform in 2010 lasted for seven months and gathered close to nine million protesters across eight different events (Chart I-7). We would compare the yellow vest protests to the 15-month long Spanish Indignados in 2011, which gathered between six and eight million protesters overall, and the U.S. Occupy Wall Street protests that same year. The two movements were similarly disorganized and combined disparate and often contradictory demands. In both cases, the governments largely ignored the protesters. Thus the yellow vests should not have a major impact on Macron’s reform agenda. As expected, Macron has not mentioned changing course on his most business-friendly reforms, which we see as a signal to investors that, despite the recent chaos, the plan remains the same. There is no strategic reason why Macron would reverse course. His popularity is already in the doldrums. His only chance at another term is to plough ahead and campaign in 2022 on his accomplishments. Nevertheless, to ensure that he does not plough into a rock, Macron will adjust course to calm the protesters. For example, the recent increase in the minimum wage that the government announced in response to the demonstrations was not supposed to be implemented until later in the presidential term. In a similar vein, pension reforms will likely be postponed given the ongoing protests. Macron hoped to introduce a universal, unified pension system by the middle of 2019 to replace an overly complex and fragmented system in which 42 different types of pension coexist, each one having its own rules of calculation. Though protests (both yellow vest and otherwise) have been unimpressive by historical standards, it might be too risky for the government to push the pension reform so close to these events. Such adjustments to the reform agenda should help reduce the protest movement’s fervour or otherwise its support. The bottom line is that the yellow vest protests were to be expected – they are the natural consequence of Emmanuel Macron’s push to reform the French economy and state. However, when compared to previous efforts to derail government reforms, the numbers simply do not stack up. Their disunited and broad objectives are likely to limit the effectiveness of the movement going forward.5 Dhaval Joshi, Chief European Investment Strategist dhaval@bcaresearch.com Jeremie Peloso, Research Analyst jeremiep@bcaresearch.com Footnotes 1 In the case of L’Oreal this refers to the L’Oreal Luxe division. 2 Please see the European Investment Strategy “Buying European Clothes: An Investment Megatrend”, dated December 6, 2018 available at eis.bcaresearch.com. 3 Deloitte: Global Powers of Luxury Goods 2018, Shaping the future of the luxury industry 4 According to the government, 10,500 “red scarves” marched in Paris on January 27, 2018. 5 For the full report, please see the Geopolitical Strategy Special Report “France: La March A Suivre?”, dated February 27, 2019, available at gps.bcaresearch.com.
The worst of the drubbing in German automobile production is likely behind us, as new orders have recently gone vertical. Backlogs are also sky-high and suggest that a definitive turn looms in German motor vehicle output. The leading indicators of Japanese…
Neutral We have successfully ridden down the S&P 1500 components index on a structural basis over the past four years. But now, factors are falling into place for an end to this multi-year bloodbath. On Monday, we lifted exposure to neutral from underweight, locking in relative gains of 36% since inception. In the U.S., light vehicle sales have been stable over the past five years and the latest Conference Board consumer confidence release showed that consumers’ plans to purchase a car remain upbeat, and could serve as a catalyst to unlock excellent relative value (middle panel). With regard to President Trump’s hawkish tariff rhetoric and the ongoing U.S./China trade tussle, automobile components makers have taken a big hit. But, there are high odds of an end to the U.S./China trade dispute. Tack on a softening greenback courtesy of a more dovish Fed. U.S. auto components producers will likely grab a larger slice of the global auto parts revenue pie (top panel). Still a number of risks keep us from turning outright bullish on this consumer discretionary subsector, including auto loan delinquencies which are increasing rapidly, approaching last cycle’s peak (bottom panel). Bottom Line: The easy money has already been made by shying away from auto component manufacturers and we lifted the S&P 1500 auto components index to neutral; please see Monday’s Weekly Report for more details. The ticker symbols for the stocks in this index are: BLBG: S15AUTC – APTV, BWA, GNTX, GT, DAN, VC, FOXF, DORM, LCII, DJPH, AXL, ADNT, CTB, THRM, GTX, SMP, CPS, MPAA, SUP.